Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Oldham

Showing results (371-380 of 566) with videos related to

Pageof 57
Sort By:
American Journal of Respiratory and Critical Care Medicine|September 17, 2019
Circulating Plasma Biomarkers of Progressive Interstitial Lung DiseaseShehabaldin Alqalyoobi, Ayodeji Adegunsoye, Angela Linderholm, et al.
The American Journal of Psychiatry|February 1, 1994
Serotonergic sensitivity in borderline personality disorder: preliminary findingsE Hollander, D J Stein, C M DeCaria, et al.
Annals of the American Thoracic Society|January 18, 2019
Computed Tomography Honeycombing Identifies a Progressive Fibrotic Phenotype with Increased Mortality across Diverse Interstitial Lung DiseasesAyodeji Adegunsoye, Justin M Oldham, Shashi K Bellam, et al.
Journal of the American Psychoanalytic Association|September 11, 2002
Psychoanalytic patients in the U.S., CANADA, and Australia: I. DSM-III-R disorders, indications, previous treatment, medications, and length of treatmentNorman Doidge, Barry Simon, Lee Brauer, et al.
Personality Disorders|March 28, 2012
Proposed changes in personality and personality disorder assessment and diagnosis for DSM-5 Part II: Clinical applicationAndrew E Skodol, Donna S Bender, John M Oldham, et al.
American Journal of Respiratory and Critical Care Medicine|December 20, 2018
Telomere Length and Use of Immunosuppressive Medications in Idiopathic Pulmonary FibrosisChad A Newton, David Zhang, Justin M Oldham, et al.
Journal of the American Psychoanalytic Association|September 11, 2002
Psychoanalytic patients in the U.S., Canada, and Australia: II. A DSM-III-R validation studyNorman Doidge, Barry Simon, William J Lancee, et al.
Lung|August 27, 2025
Changes in Lung Function and Patient-Reported Outcomes in Patients with Idiopathic Pulmonary FibrosisJamie L Todd, Megan L Neely, Anne S Hellkamp, et al.
American Journal of Respiratory and Critical Care Medicine|January 12, 2021
Monocyte Count as a Prognostic Biomarker in Patients with Idiopathic Pulmonary FibrosisMichael Kreuter, Joyce S Lee, Argyrios Tzouvelekis, et al.
AJR. American Journal of Roentgenology|March 17, 2018
CT-Pathologic Correlation of Major Types of Pulmonary Fibrosis: Insights for Revisions to Current GuidelinesJonathan H Chung, Justin M Oldham, Steven M Montner, et al.
Pageof 57

Showing results (371-380 of 566) with videos related to

Sort By:
Pageof 57
American Journal of Respiratory and Critical Care Medicine|September 17, 2019
Circulating Plasma Biomarkers of Progressive Interstitial Lung DiseaseShehabaldin Alqalyoobi, Ayodeji Adegunsoye, Angela Linderholm, et al.
The American Journal of Psychiatry|February 1, 1994
Serotonergic sensitivity in borderline personality disorder: preliminary findingsE Hollander, D J Stein, C M DeCaria, et al.
Annals of the American Thoracic Society|January 18, 2019
Computed Tomography Honeycombing Identifies a Progressive Fibrotic Phenotype with Increased Mortality across Diverse Interstitial Lung DiseasesAyodeji Adegunsoye, Justin M Oldham, Shashi K Bellam, et al.
Journal of the American Psychoanalytic Association|September 11, 2002
Psychoanalytic patients in the U.S., CANADA, and Australia: I. DSM-III-R disorders, indications, previous treatment, medications, and length of treatmentNorman Doidge, Barry Simon, Lee Brauer, et al.
Personality Disorders|March 28, 2012
Proposed changes in personality and personality disorder assessment and diagnosis for DSM-5 Part II: Clinical applicationAndrew E Skodol, Donna S Bender, John M Oldham, et al.
American Journal of Respiratory and Critical Care Medicine|December 20, 2018
Telomere Length and Use of Immunosuppressive Medications in Idiopathic Pulmonary FibrosisChad A Newton, David Zhang, Justin M Oldham, et al.
Journal of the American Psychoanalytic Association|September 11, 2002
Psychoanalytic patients in the U.S., Canada, and Australia: II. A DSM-III-R validation studyNorman Doidge, Barry Simon, William J Lancee, et al.
Lung|August 27, 2025
Changes in Lung Function and Patient-Reported Outcomes in Patients with Idiopathic Pulmonary FibrosisJamie L Todd, Megan L Neely, Anne S Hellkamp, et al.
American Journal of Respiratory and Critical Care Medicine|January 12, 2021
Monocyte Count as a Prognostic Biomarker in Patients with Idiopathic Pulmonary FibrosisMichael Kreuter, Joyce S Lee, Argyrios Tzouvelekis, et al.
AJR. American Journal of Roentgenology|March 17, 2018
CT-Pathologic Correlation of Major Types of Pulmonary Fibrosis: Insights for Revisions to Current GuidelinesJonathan H Chung, Justin M Oldham, Steven M Montner, et al.
Pageof 57